Time Trade-Off Utility Values for Health States Characterizing Progressive Muscular Degeneration in Duchenne Muscular Dystrophy (DMD)

Author(s)

Filipovic Audhya I1, Szabo S2, Bever AE2, Malone DC3, Feeny D4, Neumann PI5, Bolatova T2, Iannaccone ST6, Gooch KL1
1Sarepta Therapeutics, Cambridge, MA, USA, 2Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada, 3University of Utah, Salt Lake City, UT, USA, 4McMaster University, Hamilton, BC, Canada, 5Tufts Medical Center, Boston, MA, USA, 6University of Texas Southwestern Medical Center, Dallas, TX, USA

OBJECTIVES: The progression of DMD is characterized by loss of ambulation (LOA) and upper limb function, cardiorespiratory impairment, and early mortality. Published utility values are limited, and generally restricted to health states defined solely by ambulatory status. The objective of this study was to estimate societal utility values for health states describing the progression of DMD.

METHODS: Health states characterizing DMD progression were developed based on literature review, clinical expert consultation, and qualitative interviews with 8 patients with DMD and 26 caregivers. Members of the US general public were recruited from a market research panel, online advertising, and social media. Time trade-off utility values were elicited by a trained interviewer over Zoom, using health state descriptions and visual aids. Demographics were summarized and mean (standard deviation [SD]) utility values summarized for a set of core health states. Trends were explored according to participant sex and age (categorized as 18-24, 25-44, 45-64, and >65 years).

RESULTS: Of 190 participants, 98 (51.6%) were female and the mean (SD) age was 47 (15.3) years. Mean (SD) utility values ranged from 0.74 (0.29) for preserved/mildly impaired ambulatory function; 0.65 (0.33) for moderately/severely impaired ambulatory function; 0.48 (0.34) for non-ambulatory with preserved/mildly impaired upper limb function and non-invasive ventilation; and 0.27 (0.31) for non-ambulatory with severe loss of upper limb function and non-invasive ventilation. Utility values were relatively consistent when stratified according to participant sex; but tended to be lower with higher participant age until the oldest age category.

CONCLUSIONS: In DMD, utility values decrease in health states describing progressively more severe DMD symptoms. While utility values for the preserved ambulatory function health state are consistent with other published estimates, utility values for the range of non-ambulatory health states are higher than previous estimates that did not explicitly account for levels of upper limb function.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Code

PCR176

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities

Disease

Musculoskeletal Disorders, Pediatrics, Rare and Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×